Wolf, Natalie K.
Kissiov, Djem U. http://orcid.org/0000-0001-6279-342X
Raulet, David H. http://orcid.org/0000-0002-1257-8649
Article History
Accepted: 26 April 2022
First Online: 30 May 2022
Competing interests
: D.H.R. cofounded Dragonfly Therapeutics and served or serves on the scientific advisory boards of Dragonfly Therapeutics, Aduro Biotech and Innate Pharma; he has a financial interest in all three companies and could benefit from commercialization of the results of his research in cancer immunology. The other authors declare that they have no competing interests.